• About
• Links
• Contact
• Sitemap

ePrescribing - Infrastructure and Impact on the Healthcare Markets in the US

Technology has been used to either inform or expedite the prescribing process in most modern healthcare systems for over two decades. Recently, market forces - including greater regulatory intervention, increased investment from stakeholders and decreased resistance from end-users - have begun to converge to set the stage for widespread adoption of truly integrated ePrescribing solutions.

Scope

Insight into the different approaches taken towards adoption of ePrescribing in the US and the EU

Identification of current drivers of adoption and why they are important to the success of ePrescribing long-term

Analysis of physicians' and consumers' views on ePrescribing and how they are affecting the rate of adoption in the US and EU

Recommendations for pharmaceutical industry as to how to retain a share-of-voice in adoption, particularly as regards designing functional standards

Report Highlights
One of the greatest challenges facing ePrescribing has been finding a balance between the wants and needs of industry and end-users. Several stakeholders have been vying for influence over the design and implementation of ePrescribing systems. While this has served to move the market forward considerable conflicts of interest have also emerged.

The attitude of the physician towards ePrescribing is the most important consideration for stakeholders because it is the point at which adoption either stalls or moves forward. Historically, physicians have been offered a variety of reasons and incentives to adopt ePrescribing, with varying degrees of success.

It is the pharmaceutical industry's responsibility to ensure that decisions made at the point of care are not unduly controlled by other stakeholders, such as disruptive messaging meant to influence a physician to continuously second-guess specific prescribing decisions, or inequitable screen displays, which give preference to certain treatments.

Reasons to Purchase

Identify the dangers of the traditional paper-based prescribing model and how electronic prescribing can improve patient safety and compliance

Understand the importance of developing electronic medical records in parallel with ePrescribing initiatives

Assess opportunities for pharmaceutical companies to maintain a share-of-voice during the prescribing process

Table of Contents

• CHAPTER 1 EXECUTIVE SUMMARY - page 4
  • Scope of the report - page 4
  • Key findings - page 4
• CHAPTER 2 AN INTRODUCTION TO ELECTRONIC PRESCRIBING - page 9
  • The traditional prescribing model and its limitations - page 9
  • Market forces driving the adoption of ePrescribing - page 13
    • Greater regulatory intervention - page 13
      • A top-down approach: ongoing lessons from a centralized healthcare system - page 13
      • A bottom-up approach: ongoing lessons from a privatized healthcare system - page 15
      • The best approach: seeing ePrescribing from the eyes of the end users - page 16
    • Increased investment from stakeholders - page 18
    • Decreased resistance from end users - page 21
  • The physician's perspective - page 24
    • Physicians in the US - page 24
    • Physicians in the five major EU markets - page 27
  • The patient's perspective - page 30
  • The pharmaceutical industry's perspective - page 32
• CHAPTER 3 THE FUTURE DECODED - page 36
  • Physicians: improving patient safety by increasing use of decision-support tools - page 36
  • Patients: improving compliance by improving prescribing efficiency - page 36
  • Pharmaceutical companies: improving the prescribing process by maintaining a share-of-voice - page 39
• CHAPTER 4 BIBLIOGRAPHY - page 42
  • Referenced publications and online articles - page 42
  • Datamonitor resources - page 43
  • Further reading - page 43
• APPENDIX - page 46
  • Definitions and abbreviations - page 46
  • Extended methodology - page 46
    • Datamonitor interviews - page 46
    • Datamonitor eHealth Physician Insight Survey 2005 - page 46
    • Datamonitor eHealth Consumer Insight Survey 2005 - page 47


• List of Figures
• Figure 1: The term "ePrescribing" may or may not refer to the electronic transmission of prescriptions to the pharmacist - page 9
• Figure 2: The traditional paper-based prescribing process results in errors and inefficiencies - page 11
• Figure 3: A common national IT strategy paves the way for modernization initiatives in all healthcare systems - page 16
• Figure 4: Stakeholders in the adoption of ePrescribing are interconnected, but at times can have conflicting interests - page 19
• Figure 5: Physicians in the US and 5EU differed in their perceptions of the greatest barrier to their personal adoption of ePrescribing technologies - page 22
• Figure 6: Physicians in the US are equally likely to write a prescription electronically as they are to submit a prescription electronically, regardless of the technology used - page 25
• Figure 7: US physicians were much more positive about the likelihood that they will personally adopt ePrescribing than about the likelihood that their peers will do the same - page 26
• Figure 8: Physicians in the 5EU made the distinction between using technology to write prescriptions and using technology to transmit prescriptions directly to the pharmacist - page 27
• Figure 9: Physicians in the 5EU were somewhat more optimistic about the likelihood that they will personally adopt ePrescribing than about the likelihood that their peers will do the same - page 29
• Figure 10: Patients are open to using the Internet to improve their access to information and medications - page 31
• Figure 11: ePrescribing may present pharmaceutical companies with opportunities to gain increased access to information or improve patient compliance - page 34
• Figure 12: The prescribing process leaves patients with many opportunities to opt out of receiving or picking up a prescribed medication - page 38
• Figure 13: The pharmaceutical industry has a responsibility to ensure ePrescribing is not used as a means to influence prescribers at the point-of-care - page 40

Other users found this report page using the following search terms: eMarketing ePrescribing online drug sales eprescribing e prescribing impact patients used methodology attitude toward be

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.